CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 4 Insider Changes in Ownership
- CT ORDER Other Confidential Order
- 8-K Event Other events
- 10-Q/A Report 10-Q/A
- 8-K Event Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- SC 13G Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
Page 31 of 41 · 819 filings